These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 6957411

  • 1. Self-renewal and commitment to differentiation of human leukemic promyelocytic cells (HL-60).
    Fibach E, Peled T, Rachmilewitz EA.
    J Cell Physiol; 1982 Oct; 113(1):152-8. PubMed ID: 6957411
    [Abstract] [Full Text] [Related]

  • 2. Commitment to differentiation of human promyelocytic leukemia cells (HL60): an all-or-none event preceded by reversible losses of self-renewal potential.
    von Melchner H, Höffken K.
    J Cell Physiol; 1985 Dec; 125(3):573-81. PubMed ID: 3864784
    [Abstract] [Full Text] [Related]

  • 3. Analysis of commitment of human leukemia HL-60 cells to terminal granulocytic maturation.
    Tsiftsoglou AS, Wong W, Hyman R, Minden M, Robinson SH.
    Cancer Res; 1985 May; 45(5):2334-9. PubMed ID: 3857118
    [Abstract] [Full Text] [Related]

  • 4. Identification of a regulatory peptide distinct from normal granulocyte-derived hemoregulatory peptide produced by human promyelocytic HL-60 leukemia cells after differentiation induction with retinoic acid.
    Paukovits JB, Paukovits WR, Laerum OD.
    Cancer Res; 1986 Sep; 46(9):4444-8. PubMed ID: 3460696
    [Abstract] [Full Text] [Related]

  • 5. Changes in self-renewal potential of human leukemic cells (K562): a bidirectional stochastic process.
    von Mechner H, Höffken K.
    J Cell Physiol; 1985 May; 123(2):249-56. PubMed ID: 3856568
    [Abstract] [Full Text] [Related]

  • 6. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
    Ferrero D, Tarella C, Gallo E, Ruscetti FW, Breitman TR.
    Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
    [Abstract] [Full Text] [Related]

  • 7. Differentiation of leukemic cell lines: a review focusing on murine erythroleukemia and human HL-60 cells.
    Tsiftsoglou AS, Robinson SH.
    Int J Cell Cloning; 1985 Nov; 3(6):349-66. PubMed ID: 3905996
    [Abstract] [Full Text] [Related]

  • 8. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.
    Schwartz EL, Sartorelli AC.
    Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of growth but not differentiation of normal and leukemic myeloid cells by methylthioadenosine.
    Riscoe MK, Schwamborn J, Ferro AJ, Olson KD, Fitchen JH.
    Cancer Res; 1987 Jul 15; 47(14):3830-4. PubMed ID: 3474063
    [Abstract] [Full Text] [Related]

  • 10. Murine flt3 ligand protects M1 leukemic cells from LIF-induced differentiation and suppression of self-renewal.
    Begley CG, Rasko JE, Curtis D, Takagi K, Metcalf D, Hilton D, Roberts B, Nicola NA, Rossner MT.
    Exp Hematol; 1996 Aug 15; 24(10):1247-57. PubMed ID: 8765501
    [Abstract] [Full Text] [Related]

  • 11. Induction of differentiation in HL-60 promyelocytic cells: a comparative study in two sublines.
    Kaplinsky C, Estrov Z, Freedman MH, Cohen A.
    Blood Cells; 1986 Aug 15; 11(3):459-68. PubMed ID: 3461855
    [Abstract] [Full Text] [Related]

  • 12. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
    Nojiri H, Takaku F, Ohta M, Miura Y, Saito M.
    Cancer Res; 1985 Dec 15; 45(12 Pt 1):6100-6. PubMed ID: 3864527
    [Abstract] [Full Text] [Related]

  • 13. Induction of differentiation in human myeloid leukemic cells by proteolytic enzymes.
    Fibach E, Treves A, Kidron M, Mayer M.
    J Cell Physiol; 1985 May 15; 123(2):228-34. PubMed ID: 3884635
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation.
    Schwartz EL, Brown BJ, Nierenburg M, Marsh JC, Sartorelli AC.
    Cancer Res; 1983 Jun 15; 43(6):2725-30. PubMed ID: 6573951
    [Abstract] [Full Text] [Related]

  • 15. Control of normal differentiation of myeloid leukemic cells. XIII. Inducibility for some stages of differentiation by dimethylsulfoxide and its disassociation from inducibility by MGI.
    Maeda S, Sachs L.
    J Cell Physiol; 1978 Feb 15; 94(2):181-5. PubMed ID: 304449
    [Abstract] [Full Text] [Related]

  • 16. Expression of maturation-specific nuclear antigens in differentiating human myeloid leukemia cells.
    Murao S, Epstein AL, Clevenger CV, Huberman E.
    Cancer Res; 1985 Feb 15; 45(2):791-5. PubMed ID: 3881172
    [Abstract] [Full Text] [Related]

  • 17. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
    Drach J, McQueen T, Engel H, Andreeff M, Robertson KA, Collins SJ, Malavasi F, Mehta K.
    Cancer Res; 1994 Apr 01; 54(7):1746-52. PubMed ID: 7511050
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E, Linker-Israeli M, Umiel T, Le J, Grillier I, Said J, Shintaku IP, Krajewski S, Reed JC, Binderup L, Koeffler HP.
    Cancer Res; 1996 Aug 01; 56(15):3570-6. PubMed ID: 8758928
    [Abstract] [Full Text] [Related]

  • 20. New facts and speculations on human myeloid leukemias.
    Breitman TR, Gallo RC.
    Blood Cells; 1981 Aug 01; 7(1):79-89. PubMed ID: 6964818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.